Lv51
1268 积分 2024-11-21 加入
Advances in antibody-drug conjugates in cancer: latest updates from the 2026 AACR annual meeting
4天前
已完结
Linker Chemistry in Antibody–Drug Conjugates:Current Strategies, Clinical Pharmacokinetic Analyses, and Linker-FreeOutlooks
4天前
已完结
Recent advances in function-enhanced antibody-drug conjugates: Antibody optimization and payload combination
4天前
已完结
Process Development of Site-Specific Antibody–Drug Conjugates
11天前
已完结
Electrochemical and SEM study on Type 254 SMO stainless steel in chloride solutions
16天前
已完结
Optimization strategies for monoclonal antibody production: advances in simulation and artificial intelligence in bioprocessing
16天前
已完结
ADC Conjugation Strategies: From Technological Evolution to a Practical Selection Framework
23天前
已完结
Peptide–Drug Conjugates for Targeted Delivery in Hematological Malignancies: From Design Principles to Clinical Application
23天前
已完结
Preclinical profiles of SKB264, a novel anti-TROP2 antibody conjugated to topoisomerase inhibitor, demonstrated promising antitumor efficacy compared to IMMU-132
25天前
已完结
Now with oligos: antibody–oligonucleotide conjugates are the new drug modality to watch
1个月前
已完结
皖公网安备34019202002308
